ProSomnus (OSA) News Today → Biden FINISHED On June 13th? (From Paradigm Press) (Ad) Free OSA Stock Alerts $0.03 0.00 (0.00%) (As of 05/13/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 14 at 3:02 AM | americanbankingnews.comProSomnus (NASDAQ:OSA) versus Regenicin (OTCMKTS:RGIN) Head to Head ComparisonMay 13 at 9:16 AM | finance.yahoo.comProSomnus Contributes Two Scientific Abstracts Accepted for Presentation at the 2024 American Academy of Dental Sleep Medicine Annual MeetingMay 13 at 1:18 AM | americanbankingnews.comAnalyzing DexCom (NASDAQ:DXCM) & ProSomnus (NASDAQ:OSA)May 9, 2024 | finance.yahoo.comFour Independent Scientific Abstracts at the American Academy of Dental Sleep Medicine Annual Meeting Feature ProSomnus Intraoral Medical DevicesMay 9, 2024 | markets.businessinsider.comProSomnus Sleep Technologies Takes Strategic Action to Position Company for Long-Term SuccessApril 20, 2024 | finance.yahoo.comProSomnus, Inc. (OSA) Interactive Stock Chart - Yahoo FinanceApril 17, 2024 | msn.comProSomnus (OSA) Price Target Increased by 38.89% to 2.55March 31, 2024 | finanznachrichten.deProSomnus Sleep Technologies, Inc.: ProSomnus Reports Record Fourth Quarter and Fiscal Year 2023 Financial ResultsMarch 30, 2024 | finance.yahoo.comProSomnus, Inc. Common Stock (NASDAQ:OSA) Q4 2023 Earnings Call TranscriptMarch 28, 2024 | investorplace.comOSA Stock Earnings: ProSomnus Misses EPS, Beats Revenue for Q4 2023March 27, 2024 | finance.yahoo.comQ4 2023 Prosomnus Inc Earnings CallMarch 26, 2024 | globenewswire.comProSomnus Reports Record Fourth Quarter and Fiscal Year 2023 Financial ResultsMarch 15, 2024 | globenewswire.comProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update CallFebruary 23, 2024 | msn.comProSomnus reports pilot study data for remote OSA monitoring deviceFebruary 23, 2024 | benzinga.comTop 4 Health Care Stocks That Are Preparing To Pump This Month - ProSomnus (NASDAQ:OSA), GRI Bio (NASDAQ:GRI)February 22, 2024 | finance.yahoo.comProSomnus Reports Successful Pilot Study Validation of Next Generation Remote Patient Monitoring Device for Obstructive Sleep ApneaFebruary 22, 2024 | globenewswire.comProSomnus Reports Successful Pilot Study Validation of Next Generation Remote Patient Monitoring Device for Obstructive Sleep ApneaFebruary 20, 2024 | finance.yahoo.comProSomnus Announces Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call and Participation at the 36th Annual ROTH Conference in March 2024January 30, 2024 | finance.yahoo.comProSomnus Severe Indication 510(k) Submission Accepted for Review by the FDAJanuary 29, 2024 | finance.yahoo.comProSomnus Poised to Support Obstructive Sleep Apnea Patients Following Discontinuation of Philips Respironics OSA DevicesJanuary 23, 2024 | benzinga.comProSomnus Stock (NASDAQ:OSA) Dividends: History, Yield and DatesJanuary 8, 2024 | finance.yahoo.comProSomnus Comments on Insurance Coverage Policy Update for Obstructive and Central Sleep ApneaDecember 20, 2023 | morningstar.comProSomnus Inc OSADecember 19, 2023 | msn.comWhy Is Sleep Devices Focused ProSomnus Stock Soaring Today?December 19, 2023 | finance.yahoo.comProSomnus Treatment for Sleep Apnea Effective, Study ShowsDecember 19, 2023 | finance.yahoo.comData Published by Cureus Journal of Medical Science Shows Successful Treatment of Obstructive Sleep Apnea with ProSomnus Precision Oral Appliance DevicesNovember 29, 2023 | marketbeat.comTrading was temporarily halted for "OSA" at 02:11 PM with a stated reason of "LULD pause."November 12, 2023 | benzinga.comProSomnus Stock (NASDAQ:OSA), Analyst Ratings, Price Targets, PredictionsNovember 11, 2023 | msn.comCraig-Hallum Downgrades ProSomnus (OSA)November 9, 2023 | finance.yahoo.comProSomnus, the Leading Non-CPAP Obstructive Sleep Apnea Therapy, Reports Record Third Quarter 2023 Financial ResultsOctober 31, 2023 | finance.yahoo.comProSomnus Announces Third Quarter 2023 Investor Call and Business UpdateOctober 3, 2023 | finance.yahoo.comProSomnus Announces Participation in the 2023 Roth Capital Healthcare Opportunities ConferenceSeptember 27, 2023 | msn.comRoth MKM Maintains ProSomnus (OSA) Buy RecommendationSeptember 26, 2023 | markets.businessinsider.comRoth MKM Maintains Buy Rating for ProSomnus: Here's What You Need To KnowSeptember 21, 2023 | finance.yahoo.comProSomnus, Inc. (OSA)September 21, 2023 | finance.yahoo.comProSomnus Secures $10 Million to Drive GrowthSeptember 21, 2023 | msn.comProSomnus closes $10M preferred equity roundSeptember 21, 2023 | msn.comEXCLUSIVE: Sleep Disorder Focused ProSomnus Raises $10M To Fuel Growth, Optimize OperationsSeptember 21, 2023 | finance.yahoo.comProSomnus Raises $10 Million To Fuel Growth and Optimize OperationsSeptember 14, 2023 | finance.yahoo.comProSomnus Precision Obstructive Sleep Apnea Devices to be Featured in Scientific Abstracts and Podium Presentations at Upcoming Medical ConferencesSeptember 14, 2023 | finance.yahoo.comProSomnus Showcasing Sleep Apnea Treatment at Medical ConferencesSeptember 6, 2023 | finance.yahoo.comICR Hosts ProSomnus CEO Len Liptak on the Welcome to the Arena PodcastAugust 23, 2023 | msn.comEXCLUSIVE: ProSomnus' Device Therapy Better Than Philip's Device(s) For Sleep-Related Breathing Disorder, Study ShowsAugust 23, 2023 | finance.yahoo.comUpdated Clinical Trial Data Indicates Precision Oral Appliance Therapy with ProSomnus Devices is Non-Inferior to CPAP Therapy for the Treatment of Moderate to Severe Obstructive Sleep ApneaAugust 23, 2023 | finance.yahoo.comProSomnus Updated Clinical Trial Data Indicates Therapy is Non-Inferior to CPAPAugust 3, 2023 | finance.yahoo.comEXCLUSIVE: ProSomnus Reports Much Smaller Than Expected Q2 Loss, Revenues Inline With ConsensusAugust 3, 2023 | finance.yahoo.comProSomnus Sees Record Revenue in Second QuarterAugust 3, 2023 | finance.yahoo.comProSomnus Reports Record Second Quarter 2023 Top-Line Financial ResultsJuly 31, 2023 | markets.businessinsider.comCraig-Hallum Sticks to Its Buy Rating for ProSomnus (OSA)July 13, 2023 | finance.yahoo.comProSomnus Sleep Apnea Trial Compares Precision Therapy to Nerve Stimulation Get ProSomnus News Delivered to You Automatically Sign up to receive the latest news and ratings for OSA and its competitors with MarketBeat's FREE daily newsletter. Email Address America’s worst nightmare? (Ad)What This Group Has Planned for the 2024 Election Will Shock You Controversial new exposé reveals what’s really going on in America, what it means for your money, and what you must do to protect your assets before it’s too late. Click here to watch this bombshell exposé now. OSA Media Mentions By Week OSA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OSA News Sentiment▼0.140.57▲Average Medical News Sentiment OSA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OSA Articles This Week▼51▲OSA Articles Average Week Get ProSomnus News Delivered to You Automatically Sign up to receive the latest news and ratings for OSA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: NURO News VAPO News VVOS News PSTV News INBS News AVGR News BTCY News TMDIF News VERO News PETV News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OSA) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a CenturyStarpaxDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldThis 1 Biotech Stock has been shocking the marketsHuge AlertsClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsREAD THIS – If You Missed Out On The AI BoomBanyan Hill PublishingElon’s New Device is About to Shock the WorldInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProSomnus, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
